Effects of cessation of a policy of neonatal fluconazole prophylaxis on fungal resurgence

Indian Pediatrics

Volumn 42, Issue 12, 2005, Pages 1226-1230

  Dutta, Sourabh ^a   Murki, Srinivas ^a   Varma, Sanjeev ^a   Narang, Anil ^a   Chakrabarti, Arunaloke ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Fluconazole prophylaxis; Fungal infection; Resistance

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; PYRROLE DERIVATIVE;

ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOSIS; NEWBORN; PROPHYLAXIS; SEPSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ANTIFUNGAL AGENTS; FEMALE; FLUCONAZOLE; FUNGEMIA; HUMANS; INCIDENCE; INDIA; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MALE; ORGANIZATIONAL POLICY; RETROSPECTIVE STUDIES;

EID: 32644436465     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Chapman RL. Candida infections in the neonate. Curr Opin Pediatr 2003; 12: 97-102.
2. Saiman L, Ludington E, Dawson JD, Paterson JE, Randgel-Frausto S, Wiblin RT, et al. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J 2001; 20: 1119-1124.
3. Rodero L, Hochenfellner F, Demkura H, Pereda R, Coroba S, Canteros C, et al. Nosocomial transmission of candida albicans in newborn infants. Rev Argent Microbiol 2000; 32: 179-184.
4. McGurie W, Clerihew L, Austin N. Prophylactic intravenous antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database Syst Rev. 2004; 1: CDO03850.
5. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 2001; 345: 1660-1666.
6. Kicklighter SD, Springer SC, Cox T, Hulsey TC, Turner RB. Fluconazole for prophylaxis against Candidal rectal colonization in the very low birth weight infant. Pediatrics 2001; 107:293-298.
7. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for anti-microbial susceptibility testing; Twelfth informational supplement. vol 22: NCCLS document M100-S12, 2002.